Universal public finance of tuberculosis treatment in India: An extended cost-effectiveness analysis

Health Economics (United Kingdom)

Volumn 24, Issue 3, 2015, Pages 318-332

  Verguet, Stéphane ^a   Laxminarayan, Ramanan ^b,c,d   Jamison, Dean T ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b PUBLIC HEALTH FOUNDATION OF INDIA   (India)

^c Economics and Policy   (United States)

^d PRINCETON UNIVERSITY   (United States)

Author keywords

Extended cost effectiveness analysis; Financial protection; Health policy instruments; India; Insurance; Public finance; Tuberculosis

Indexed keywords

TUBERCULOSTATIC AGENT;

ARTICLE; COST CONTROL; COST EFFECTIVENESS ANALYSIS; EXTRAPULMONARY TUBERCULOSIS; FATALITY; GOVERNMENT; HEALTH CARE COST; HEALTH CARE POLICY; HOUSEHOLD; HUMAN; INCOME; INDIA; MORBIDITY; POSTPRIMARY TUBERCULOSIS; POVERTY; PRIORITY JOURNAL; PRIVATE HEALTH INSURANCE; PUBLIC HEALTH INSURANCE; PURCHASING; QUALITY OF LIFE; RISK FACTOR; SHORT COURSE THERAPY; SPUTUM SMEAR; TUBERCULOSIS; COST BENEFIT ANALYSIS; ECONOMICS; HEALTH CARE DELIVERY; ORGANIZATION AND MANAGEMENT; PUBLIC HEALTH; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA;

ANTITUBERCULAR AGENTS; COST-BENEFIT ANALYSIS; HEALTH EXPENDITURES; HEALTH SERVICES ACCESSIBILITY; HUMANS; INDIA; MODELS, ECONOMETRIC; NATIONAL HEALTH PROGRAMS; TUBERCULOSIS;

EID: 84922211382     PISSN: 10579230     EISSN: 10991050     Source Type: Journal    
DOI: 10.1002/hec.3019     Document Type: Article

References (78)

1. Ananthakrishan R, Muniyandi M, Jeyaraj A, Palani G, Sathiyasekaran BWC. 2012. Expenditure pattern for TB treatment among patients registered in an urban government of DOTS program in Chennai City, South India. 2012. Tuberculosis Research and Treatment 2012: 747924. doi: 10.1155/2012/747924.
2. Arrow KJ. 1965. Aspects of the Theory of Risk Bearing. Academic Bookstores: Helsinki.
3. Baicker K, Levy H. 2012. The insurance value of Medicare. New England Journal of Medicine 367: 1773-1775.
4. Banerjee AV, Duflo E. 2007. The economic lives of the poor. Journal of Economic Perspectives 21(1): 141-167.
5. Banerjee AV, Duflo E, Glennerster R, Khotari D. 2010. Improving immunisation coverage in rural India: clustered randomised controlled evaluation of immunisation campaigns with and without incentives. British Medical Journal 340: c2220. doi:10.1136/bmj.c2220.
6. Brown JR, Finkelstein A. 2008. The interaction of public and private insurance: Medicaid and the long-term care insurance market. American Economic Review 98(3): 1083-1102.
7. Cagetti M, de Nardi M. 2006. Entrepreneurship, frictions and wealth. Journal of Political Economy 114(5): 835-870.
8. Castillo-Chavez C, Song B. 2004. Dynamical models of tuberculosis and their applications. Mathematical Biosciences and Engineering 1: 361-404.
9. Chatterjee P. 2010. India tries to break cycle of health-care debt. Bulletin of the World Health Organization 88: 486-487.
10. Cookson R, Drummond M, Weatherly H. 2009. Explicit incorporation of equity considerations into economic evaluation of public health interventions. Health Economics, Policy, and Law 4(2): 231-245.
11. Culyer AJ, Bombard Y. 2012. An equity framework for health technology assessments. Medical Decision Making 32: 428-441.
12. Davis SJ, Kubler F, Willen P. 2006. Borrowing costs and the demand for equity over the life cycle. The Review of Economics and Statistics 88(2): 348-362.
13. Dye C, Floyd K. 2006. Tuberculosis. Disease Control Priorities in Developing Countries (2nd edn), Jamison DT, Breman JG, Measham AR, Alleyne G, Clamson M, Evans DB, Jha P, Mills A, Musgrove P (eds.). The World Bank: Washington, DC.
14. Engen EM, Gale WG, Uccello CE. 1999. The adequacy of household saving. Brookings Papers on Economic Activity 2: 65-187.
15. Feldstein M, Gruber J. 1995. A major risk approach to health insurance reform. Tax Policy and the Economy 9: 103-130.
16. Fernald LCH, Gertler PJ, Neufeld LM. 2008. Role of conditional cash transfer programmes for child health, growth, and development: an analysis of Mexico's Oportunidades. Lancet 371: 828-837.
17. Finkelstein A, McKnight R. 2008. What did Medicare do? The initial impact of Medicare on mortality and out of pocket medical spending. Journal of Public Economics 92: 1644-1668.
18. Fleurbaey M, Luchini S, Muller C, Schokkaert E. 2012. Equivalent income and fair evaluation of health care. Health Economics 22(6): 711-729.
19. Geetharamani S, Muniyandi M, Rajeswari R, Balasubramanian R, Theresa X, Venkatesan P. 2001. Socio-economic impact of parental tuberculosis on children. Indian Journal of Tuberculosis 48: 91-94.
20. Gertler P, van der Gaag J. 1990. The Willingness to pay for Medical Care in Developing Countries. Johns Hopkins University Press: Baltimore.
21. Gertler P, Gruber J. 2002. Insuring consumption against illness. American Economic Review 92: 51-70.
22. Griffin S, Cookson R, Rice N, Asaria M, Claxton K, Culyer T, Sculpher M. 2012. Incorporating health inequality concerns into cost-effectiveness analysis - overview. Center for Health Economics, University of York: York, United Kingdom. http://www.york.ac.uk/media/che/documents/Overview%20Paper%20-%20Incorporating%20Health%20Inequality%20Concerns%20into%20Cost-Effectiveness%20Analysis.pdf. [22 March 2013].
23. Hubbard RG, Skinner J, Zeldes SP. 1995. Precautionary saving and social insurance. Journal of Political Economy 103(2): 360-399.
24. Hurd MD. 1989. Mortality risk and bequests. Econometrica 57(4): 789-813.
25. Jamison DT. 2009. Cost effectiveness analysis: concepts and applications. Oxford Textbook of Public Health, The Methods of Public Health (5th edn), Detels R, McEwen J, Beaghole R, Lansang MA, Gulliford M (eds.). Oxford University Press: New York.
26. Jamison DT, Summers LH, Alleyne G, Arrow KJ, Berkley S, Binagwaho A, et al. 2013. Global health 2035: a world converging within a generation. Lancet 382: 11-68.
27. Jha P, Laxminarayan R. 2009. Choosing health in India: An entitlement for all Indians. University of Toronto and Resources for the Future: New Delhi.
28. Institute for Health Metrics and Evaluation (IHME). 2013. Global Burden of Disease Study 2010. http://www.healthmetricsandevaluation.org/gbd/visualizations/gbd-cause-patterns [28 May 2013].
29. Islam MA, May MA, Ahmed F, Cash R, Ahmed J. 2011. Making Tuberculosis History: Community-Based Solutions for Millions. The University Press Limited: Dhaka, Bangladesh.
30. Keane MP, Wolpin KI. 2001. The effect of parental transfers and borrowing constraints on educational attainment. International Economic Review 42(4): 1051-1103.
31. King G, Gakidou E, Imai K, Lakin J, Moore RT, Nall C, Ravishankar N, Vargas M, Tellez-Rojo MM, Hernandez Avila JE, Hernandez Llamas H. 2009. Public policy for the poor? A randomized assessment of the Mexican universal health insurance programme. Lancet 373: 1447-1454.
32. Knaul FM, Arreola-Ornelas H, Mendez-Carniado O, Bryson-Cahn C, Maguire R, Miranda M, Sesma S. 2006. Evidence is good for your health system: policy reform to remedy catastrophic and impoverishing health spending in Mexico. Lancet 368: 1828-1841.
33. Kumar M, Kumar S. 1997. Tuberculosis control in India: role of private doctors. Lancet 350: 1329-1330.
34. Kruk ME, Goldmann E, Galea S. 2009. Borrowing and selling to pay for health care in low- and middle-income countries. Health Affairs 28(4): 1056-1066.
35. Laibson DI, Repetto A, Tobacman J. 1998. Self-control and saving for retirement. Brookings papers on economic activity 1: 91-172.
36. Lim SS, Dandona L, Hoisington JA, James SC, Hogan MC, Gakidou E. 2010. India's Janani Suraksha Yojana, a conditional cash transfer programme to increase births in health facilities: an impact evaluation. Lancet 375: 2009-2023.
37. Mauskopf JA, Paul JE, Grant DM, Stergachis A. 1998. The role of cost-consequence analysis in healthcare decisionmaking. PharmacoEconomics 13(3): 277-288.
38. McClellan M, Skinner J. 2006. The incidence of Medicare. Journal of Public Economics 90: 257-276.
39. Mitchell OS, Poterba JM, Warshawsky MJ, Brown JR. 1999. New evidence on the money's worth of individual annuities. American Economic Review 89(5): 1299-1318.
40. Muniyandi M, Ramachadran R, Gopi PG, Chandrasekaran V, Subramani R, Sadacharam K, Kumaran P, Santha T, Wares F, Narayanan PR. 2007. The prevalence of tuberculosis in different economic strata: a community survey from South India. International Journal of Tuberculosis Lung Disease 11(9): 1042-1045.
41. Muniyandi M, Ramachandran R, Balasubramanian R, Narayanan PR. 2006. Socio-economic dimensions of tuberculosis control: review of studies over two decades from Tuberculosis Research Center. Journal of Communicable Diseases 38(3): 204-215.
42. Muniyandi M, Rajeswari R, Balasubramanian R, Narayanan PR. 2008. A comparison of costs to patients with tuberculosis treated in a DOTS programme with those in a non-DOTS programme in South India. Journal of Health Management 10(1): 9-24.
43. Murray CJL, Styblo K, Rouillon A. 1990. Tuberculosis in developing countries: burden, intervention and cost. Bulletin of the International Union Against Tuberculosis and Lung Disease 65(1): 6-24.
44. National Sample Survey Organisation. 2004. National Sample Survey Round 60. Ministry of Statistics and Programme Implementation. Government of India: New Delhi.
45. Niruparani C, Beena T, Basilea W, Raja SM, Chandrasekeran V, Fraser W. 2010. Care seeking behavior of chest symptomatics: a community based study done in South India after the implementation of the RNTCP. PloS ONE 5(9): e12379.
46. Norheim OF. 2013. Atkinson's measure of inequality: can measures of economic inequality help us understand trade-offs in healthcare priority setting? Inequalities in health. Concepts, measures, and ethics, Eyal N, Hurst SA, Norheim OF, Wikler D (eds.), Oxford University Press: New York.
47. Nyman JA. 1999. The value of health insurance. Journal of Health Economics 18: 141-152.
48. Pratt JW. 1964. Risk aversion in the small and in the large. Econometrica 32(1): 122-136.
49. Rajeswari R, Balasubramanian R, Muniyandi M, Geetharamani S, Thresa X, Venkatesan P. 1999. Socio-economic impact of tuberculosis on patients and family in India. The International Journal of Tuberculosis and Lung Disease 3(10): 869-877.
50. Rao S. 2009. Tuberculosis and patient gender: an analysis and its implications in tuberculosis control. Lung India 26(2): 46-47.
51. Roberts MJ, Hsiao W, Berman P, Reich MR. 2004. Getting Health Reform Right: A Guide to Improving Performance and Equity. Oxford University Press: New York, NY.
52. Rosenzweig MR, Wolpin KI. 1993. Credit market constraints, consumption smoothing, and the accumulation of durable production assets in low-income countries: investments in bullocks in India. Journal of Political Economy 101(2): 223-244.
53. Salem ABZ, Mount TD. 1974. A convenient descriptive model of income distribution: the Gamma density. Econometrica 42 (6): 1115-1127.
54. Sassi F, Archard L, Le Grand J. 2001. Equity and the economic evaluation of healthcare. Health Technology Assessment 5(3): 1-138.
55. Satyanarayana S, Nair SA, Chadha SS, Shivashankar R, Sharma G, Yadav S, Mohanty S, Kamineni V, Wilson NC, Harries AD, Dewan PK. 2011. From where are tuberculosis patients accessing treatment in India? Results from a cross-sectional community based survey of 30 districts. PloS ONE 6(9): e24160.
56. Scholz JK, Seshadri A, Khitatrakun S. 2006. Are Americans saving "optimally" for retirement? Journal of Political Economy 114(4): 607-643.
57. Sengupta A, Nundy S. 2005. The private health sector in India. British Medical Journal 331: 1157-1158.
58. Smith PC. 2007. Provision of a public benefit package alongside private voluntary health insurance. Private Voluntary Health Insurance in Development: Friend or Foe? Preker AS, Scheffer RM, Bassett MC (eds.). The World Bank: Washington, DC.
59. Smith PC. 2013. Incorporating financial protection into decision rules for publicly financed healthcare treatments. Health Economics 22: 180-193.
60. Thornton RL. The demand and impact of learning HIV status. 2008. American Economic Review 98: 1829-1863.
61. Udwadia ZF, Pinto LM, Uplekar MW. 2010. Tuberculosis management by private practitioners in Mumbai, India: has anything changed in two decades? PloS One 5(8): e12023.
62. Uplekar MW, Shepard DS. 1991. Treatment of tuberculosis by private general practitioners in India. Tubercle 72: 284-290.
63. Uplekar M, Juvekar S, Morankar S. 1996. Tuberculosis patients and practitioners in private clinics. The Foundation for Research in Community Health.
64. Uplekar M, Pathania V, Raviglione M. 2001. Private practitioners and public health: weak links in tuberculosis control. Lancet 358: 912-916.
65. van Doorlsaer E, O'Donnell O, Rannan-Eliya RP, Somanathan A, Adhikari SR, Garg CC, et al . 2006. Effect of payments for health care on poverty estimates in 11 countries in Asia: an analysis of houselhold survey data. Lancet 368: 1357-1364.
66. van Doorlsaer E, O'Donnell O, Rannan-Eliya RP, Somanathan A, Adhikari SR, Garg CC, et al. 2007. Catastrophic payments for health care in Asia. Health Economics 16: 1159-1184.
67. Wagstaff A. 2010. Measuring financial protection in health. Performance Measurement for Health System Improvement, Smith PC, Mossialos E, Papanicolas I, Leatherman S (eds.), Cambridge University Press: Cambridge.
68. Wagstaff A, van Doorslaer E. 2003. Catastrophe and impoverishment in paying for health care: its applications to Vietnam 1993-1998. Health Economics 12: 921-934.
69. World Bank. 1993. World Development Report 1993: Investing in health. Oxford University Press: New York.
70. World Bank. 1997. Sector Strategy: Health, Nutrition and Population. The World Bank: Washington, DC.
71. World Bank. 2012. World Development Indicators. The World Bank: Washington, DC. http://data.worldbank.org/data-catalog/world-development-indicators. [20 November, 2012].
72. World Health Organization. 1999. World Health Report 1999: Making a Difference. World Health Organization: Geneva.
73. World Health Organization. 2000. World Health Report 2000: Health Systems: Improving Performance. World Health Organization: Geneva.
74. World Health Organization. 2010. World Health Report 2010: Health systems financing, the path to universal coverage. World Health Organization: Geneva.
75. World Health Organization. 2009. Global Tuberculosis Control. WHO Report 2009. World Health Organization: Geneva.
76. World Health Organization. 2011. Global Tuberculosis Control. WHO Report 2011. World Health Organization: Geneva.
77. World Health Organization. 2012. Global Tuberculosis Control. WHO Report 2012. World Health Organization: Geneva.
78. Xu K, Evans DB, Kawabata K, Zeramdini R, Klavus J, Murray CJL. 2003. Household catastrophic health expenditure: a multicountry analysis. Lancet 362: 111-117.